Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com IMRICOR ’ S U.S. COMMERCIAL MOMENTUM ACCELERATES CHILDREN ’ S MEDICAL CENTER DALLAS TO BECOME SECOND U.S. CUSTOMER Key...
Imricor U.S. Commercial Momentum Accelerates
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Imricor Medical Systems, Inc. announces that Children’s Medical Center Dallas will become its second U.S. customer for the NorthStar iMR mapping and guidance system, following Rady Children’s Hospital–San Diego as the first customer. This adoption marks a significant step in Imricor's U.S. commercial operations, which launched recently, and highlights the growing momentum in the market for their technology. The hospital will implement a NorthStar-guided cardiac catheterization program, providing radiation-free procedures for children with congenital heart disease. Imricor expects additional U.S. hospitals to finalize their purchasing processes soon, indicating a strong demand for their innovative solutions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Imricor Medical Systems, Inc. on 6ix
In the deck
Earlier from Imricor Medical Systems
- 1H 2026 Investor Presentation
- 2026 Q2 Form 10-Q
- Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
- Philips Declares Compatibility with Imricor
- Q2 FY26 Results Webinar Notification
Later from Imricor Medical Systems
- Imricor and Philips Launch Commercial iMR Lab Solution
- Release from Voluntary Escrow
- FDA Accepts Imricor PMA Manufacturing Module
- S&P DJI Announces September 2026 Quarterly Rebalance
- Application for quotation of securities - IMR
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems